Identifying market risk for substandard and falsified medicines

Global perspective of the risks of falsified and counterfeit medicines

Counterfeit pharmaceuticals, originating from within the region or imported from other sources, can enter both domestic and international markets [113,114]. In ...

Substandard and Falsified Medicines: Proposed Methods for Case ...

Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia ...

Prevalence and Estimated Economic Burden of Substandard and ...

Importance Substandard and falsified medicines burden health systems by diverting resources to ineffective or harmful therapies, causing medical ...

Counterfeits, Substandard Drugs and Drug Diversion

The license should be revoked if a license holder is found to market illegal or fake drugs, or ... IFPMA, Counterfeit Drugs, a Global Health Risk, in.

Substandard and falsified medicines in African pharmaceutical ...

The WHO (2017) define substandard medicines as "approved medical items that fail to meet their quality requirements, specifications, or both”.

Health, Economic, and Social Impacts of Substandard and Falsified ...

Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia ...

Substandard and Falsified Medicines

Substandard and falsified medical products must be considered to be unsafe and ineffective. They result in wasted resources spent on purchasing, inventory, ...

Combatting Substandard and Falsified Medicines: Public ... - Frontiers

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications ... Objectives: The objective of this study was to ...

Stakeholder perspectives on the demand and supply factors driving ...

... identified as driving risk of substandard and falsified blood pressure lowering medications ... Identifying market risk for substandard and falsified medicines: ...

Identifying and Avoiding Substandard and Falsified Medical Products

In today's global pharmaceutical market, the prevalence of substandard and falsified medical products poses a significant threat to public ...

The uncertain role of substandard and falsified medicines in ... - Nature

Improved risk-based post-market surveillance for SF medicines will ... Technologies for detecting falsified and substandard drugs in ...

Substandard and falsified medicines: global and local efforts to ...

Substandard medicines · Falsified medicines · Substandard and falsified antimicrobials · Under-reporting of incidence · Poor detection methods · Lack ...

(PDF) Substandard and falsified medicines: proposed methods for ...

We further propose a risk-based sentinel surveillance system which concentrates resources on measuring the prevalence of substandard and falsified medicines in ...

Public Awareness and Identification of Counterfeit Medications

Combatting Substandard and Falsified Medicines. Regulatory Authority (NRRA) for the market in which they are marketed or distributed are ...

Substandard and Falsified Medical Products

Urges governments to recognise the risk that SF medical products pose ... Pharmacovigilance of biotherapeutic medicines: Identifying global cases studies.

COVID-19 and risks to the supply and quality of tests, drugs, and ...

Without preparation for the quality assurance of diagnostic tests, drugs, and vaccines, the world risks a parallel pandemic of substandard and falsified ...

Avoiding Poorly Regulated Medicines & Medical Products ... - CDC

Poor regulatory oversight breeds poor-quality medicines, whether they are counterfeit, falsified, substandard, or degraded.

Manage Risk When Investigating Counterfeit Pharmaceuticals

The World Health Organization (WHO) estimates that 1 in 10 medical products in low- and middle-income countries is falsified or substandard. But they aren't the ...

Modeling the Health and Economic Impact of Substandard and ...

ABSTRACT. Substandard and falsified medicines are harmful to patients, causing prolonged illness, side effects, and preventable deaths.

Organized Crime Module 3 Key Issues: Falsified Medical Products

In other words, in low and middle-income countries, 1 in 10 medical products is either falsified or substandard. The value of this market is estimated at US$ 30 ...